Location History:
- Annecy, FR (2011)
- Epagny, FR (2015 - 2018)
Company Filing History:
Years Active: 2011-2018
Title: Olivier Benoit: Innovator in Injectable Formulations for Osteoarthritis Treatment
Introduction
Olivier Benoit is a notable inventor based in Epagny, France. He has made significant contributions to the field of injectable formulations, particularly in the treatment of osteoarthritis. With a total of 3 patents, his work focuses on developing innovative solutions for joint degeneration.
Latest Patents
Benoit's latest patents include an injectable formulation of natural polysaccharide and polyol for the treatment of osteoarthritis. This sterile injectable aqueous formulation is designed as a gel made up of hyaluronic acid or a salt thereof, combined with one or more polyols. The gel can be applied to the intra-articular area, effectively addressing joint degeneration and osteoarthritis. The formulation exhibits rheological properties similar to synovial fluid and demonstrates elevated resistance to degradation due to the synergistic action between hyaluronic acid and polyols. Another significant patent involves the use of a natural polysaccharide gel for preparing an injectable formulation aimed at treating articular degeneration. This formulation also consists of hyaluronic acid, with or without other natural polysaccharides, and one or more polyols, ensuring effective intra-articular application.
Career Highlights
Throughout his career, Olivier Benoit has worked with reputable companies such as Aptissen SA and Anteis S.A. His experience in these organizations has contributed to his expertise in developing advanced medical formulations.
Collaborations
Benoit has collaborated with notable professionals in his field, including Samuel Gavard Molliard and Laurence Hermitte. These collaborations have further enriched his work and innovations.
Conclusion
Olivier Benoit stands out as an influential inventor in the realm of injectable formulations for osteoarthritis treatment. His innovative patents and collaborations reflect his commitment to advancing medical solutions for joint health.